Medicamentos Oncohematológicos evaluados por GENESIS (2007 – 2018)
NewsRARE 4. El acceso a los medicamentos huérfanos
El Análisis de Decisión Multi-Criterio como herramienta para la toma de decisiones en MMHH: una revisión de la literatura
Cost–utility analysis of germline BRCA1/2 testing in women with high‑grade epithelial ovarian cancer in Spain
A systematic review of economic evaluations in non-insulin antidiabetic treatments for patients with type 2 Diabetes Mellitus
Budget impact analysis of low-dose methoxyflurane for the treatment of moderate-to-severe trauma pain in conscious adult patients in Spain
Cost-Utility Analysis of the germline BRCA testing in Women with epithelial ovarian cancer without family history in Spain
Social Return on Investment of an ideal approach to Multiple Sclerosis within the SNHS
